title: Pneumococcal vaccine – Prevenar 13
text: |
  Pneumococcal vaccine – Prevenar 13
  |
  bet | 483/654 | Sana | 03.01.2022 | Hajmi | 1,5 Mb. | | #14803 |
  Pneumococcal vaccine – Prevenar 13
  Revision Date : 2-3-2020
  |
  Approved : TC, KOH
  |
  Alert
  |
  Increased risk of fever when pneumococcal conjugate vaccine concurrently administered with other vaccines.
  Register the vaccination with the National Immunisation Registry by faxing a copy of the immunisation details from “My personal health record” to Anne Allen on 93824309.
  |
  Indication
  |
  1. Primary immunisation against pneumococcal disease in infants at 6 weeks/2 months, 4 and 6 months of age.
  2. Booster dose at 12 months in at risk children:
  Indigenous children in Northern Territory, Queensland, South Australia or Western Australia.
  Children with a medical condition associated with an increased risk of invasive pneumococcal disease.
  Preterm infants < 28 weeks gestation
  3. Catch-up vaccination schedules in children up to 5 years of age.
  |
  Action
  |
  Induces the production of antibodies against Streptococcus pneumoniae.
  |
  Drug Type
  |
  Vaccine
  Conjugated pneumococcal vaccine composed of pneumococcal serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F each conjugated to CRM197 carrier protein.
  |
  |
  |
  | |